Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 Feb 1;13(2):e13063.
doi: 10.7759/cureus.13063.

Intraductal Papillary Neoplasm of the Bile Duct: A Rare Case of Intrahepatic Space-Occupying Lesion

Affiliations
Case Reports

Intraductal Papillary Neoplasm of the Bile Duct: A Rare Case of Intrahepatic Space-Occupying Lesion

Souradeep Dutta et al. Cureus. .

Abstract

Intraductal papillary neoplasm of the bile duct (IPNB) is a rare tumor and is considered one of the precursor lesions for cholangiocarcinoma. Though relatively common in the far east countries, it is uncommon in the Indian population. A 67-year-old gentleman presented with vague upper abdominal pain with no history of fever, jaundice, melena, or hematemesis. An abdominal ultrasound showed a solid cystic lesion in the left lobe of the liver with upstream dilatation of bile ducts. Computed tomography and magnetic resonance imaging showed similar findings. With a differential diagnosis of intrahepatic cholangiocarcinoma, intraductal papillary neoplasm, and biliary cystadenoma, he underwent robotic-assisted left hepatectomy. Histopathology was suggestive of IPNB. Following surgery, he had an uneventful recovery and was advised for follow-up visits every six months. A clinical, radiological, and pathological profile of this rare tumor has been described here with a review of the existing literature.

Keywords: biliary papillomatosis; bt-ipmn; cholangiocarcinoma; intraductal papillary neoplasm of bile duct; ipnb.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. CT images. IPNB lesion is marked with a white arrow. Dilated left-sided biliary radicles are shown with white arrowheads. (A) Axial section, non-contrast (plain) phase; (B) axial section, arterial phase; (C) axial section, portal phase; (D) reconstructed coronal section, delayed phase.
CT, computed tomography; IPNB, intraductal papillary neoplasm of the bile duct
Figure 2
Figure 2. MRI images. (A) T1-weighted axial section with low to isointense lesion (white arrow); (B) T2-weighted axial section with hyperintense lesion with intraductal papillary projections (white arrow); (C) 3D volume reconstructed MRCP image showing the cystic lesion with communication with LHD which is causing proximal dilatations of the biliary ducts.
MRI, magnetic resonance imaging; MRCP, magnetic resonance cholangiopancreatography; RAD, right anterior sectoral duct; RPD, right posterior sectoral duct; GB, gall bladder; LHD, left hepatic duct
Figure 3
Figure 3. (A, B) Intraoperative robotic surgery images showing the nodular surface of the left lobe of the liver (black arrows) in contrast to the smooth surface of the right side; (C) resected specimen of the left lobe of the liver (posterior surface).
II, III, IVa, IVb, demonstrating the respective liver segments; IPNB, intraductal papillary neoplasm of the bile duct
Figure 4
Figure 4. Histopathological images. (A) Section showing a cystic lesion with a thin rim of liver parenchyma (painted end). The cyst is lined by columnar epithelium thrown into complex papillary processes, hematoxylin and eosin stain, ×40; (B) Section showing higher magnification of the lesion with stratified lining exhibiting prominent nucleoli, occasional mitoses, and moderate nuclear pleomorphism with evidence of intracytoplasmic mucin, hematoxylin and eosin stain, ×400; (C) Section showing tumor cells exhibiting spare cytoplasmic expression of cytokeratin 7. Immunohistochemistry with DAKO polyclonal antibody for cytokeratin 7, diaminobenzidine stain, ×200; (D) Section showing tumor cells exhibiting strong diffuse cytoplasmic expression of cytokeratin 19. Immunohistochemistry with DAKO polyclonal antibody for cytokeratin 19, diaminobenzidine stain, ×200.

Similar articles

Cited by

References

    1. Precancerous lesions of the biliary tree. Klöppel G, Adsay V, Konukiewitz B, Kleeff J, Schlitter AM, Esposito I. Best Pract Res Clin Gastroenterol. 2013;27:285–297. - PubMed
    1. Mucinous cystic neoplasm of the liver or intraductal papillary mucinous neoplasm of the bile duct? A case report and a review of literature. Kunovsky L, Kala Z, Svaton R, Moravcik P, Mazanec J, Husty J, Prochazka V. Ann Hepatol. 2018;17:519–524. - PubMed
    1. Intraductal papillary neoplasm of the bile duct: a rarity. Bal M, Goel M, Ramadwar M, Deodhar K. Indian J Pathol Microbiol. 2014;57:144–145. - PubMed
    1. Biliary tract intraductal papillary mucinous neoplasm: a brief report and review of literature. Subhash R, Valiyaveettil IA, Natesh B, Raji L. Indian J Pathol Microbiol. 2014;57:588–590. - PubMed
    1. Intraductal papillary neoplasm of the bile duct. Wan XS, Xu YY, Qian JY, et al. World J Gastroenterol. 2013;19:8595–8604. - PMC - PubMed

Publication types

LinkOut - more resources